Effect of dolutegravir-based antiretroviral therapy on weight
Treatment-naïve HIV-infected patients starting dolutegravir-based regimens gain significantly more weight at 18 months than those starting NNRTI-based and elvitegravir-based regimens
Journal Watch by
Dr Grant Hill-CawthorneSensitivity and specificity of a hepatitis B core-related antigen immunoassay for assessing treatment eligibility
Hepatitis B core-related antigen may be an accurate alternative to hepatitis B virus DNA quantification as a simple and inexpensive tool to identify HBV-infected patients in need of antiviral therapy in low- and middle-income countries.
Contribution of congenital cytomegalovirus infection to early onset hearing loss
Congenital cytomegalovirus infection is an important cause of permanent hearing impairment in childhood in all settings
Safety and immunogenicity of two oral type-2 poliovirus vaccine candidates
Two novel oral poliovirus type-2 vaccine candidates are safe and immunogenic in inactivated poliovirus vaccine-immunised adults.